Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis

Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis

(2014) Louis Yi Ann Chai et al.   PLoS One

The Serum Galactomannan Index Predicts Mortality in Hematopoietic Stem Cell Transplant Recipients With Invasive Aspergillosis

(2013) Cynthia E. Fisher et al.   CLINICAL INFECTIOUS DISEASES

SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients

(2013) M. T. Montagna et al.   INFECTION

(1,3)- -D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis

(2012) S. Jaijakul et al.   CLINICAL INFECTIOUS DISEASES

Post-diagnostic kinetics of the (1 → 3)-β-d-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia

(2012) S. Koo et al.   CLINICAL MICROBIOLOGY AND INFECTION

Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis

(2012) L. Y. A. Chai et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Persistence of a Positive (1,3)-β-d-Glucan Test after Clearance of Candidemia in Hematopoietic Stem Cell Transplant Recipients

(2011) M. Mikulska et al.   Clinical and Vaccine Immunology

Kinetics of Serum β-D-Glucan after Pneumocystis Pneumonia Treatment in Patients with AIDS

(2011) Michiko Koga et al.   INTERNAL MEDICINE

Diagnosis of Invasive Fungal Disease Using Serum (1→3)-β-D-Glucan: A Bivariate Meta-Analysis

(2011) Yuan Lu et al.   INTERNAL MEDICINE

Prospective Evaluation of Clinical and Biological Markers To Predict the Outcome of Invasive Pulmonary Aspergillosis in Hematological Patients

(2011) A. Bergeron et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis

(2010) S. Koo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Galactomannan serves as a surrogate endpoint for outcome of pulmonary invasive aspergillosis in neutropenic hematology patients

(2009) Johan Maertens et al.   CANCER

Serum (1→3) β‐d‐Glucan as a Noninvasive Adjunct Marker for the Diagnosis ofPneumocystisPneumonia in Patients with AIDS

(2009) Tamayo Watanabe et al.   CLINICAL INFECTIOUS DISEASES

Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease

(2009) Sophia Koo et al.   CLINICAL INFECTIOUS DISEASES

Editorial Commentary: AspergillusGalactomannan Index: A Surrogate End Point to Assess Outcome of Therapy?

(2008) Kieren A. Marr   CLINICAL INFECTIOUS DISEASES

Strong Correlation between Serum Aspergillus Galactomannan Index and Outcome of Aspergillosis in Patients with Hematological Cancer: Clinical and Research Implications

(2008) Marisa H. Miceli et al.   CLINICAL INFECTIOUS DISEASES

Factors Associated with Overall and Attributable Mortality in Invasive Aspergillosis

(2008) Yasmine Nivoix et al.   CLINICAL INFECTIOUS DISEASES

Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

(2008) Brahm H. Segal et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry

(2008) D. Neofytos et al.   CLINICAL INFECTIOUS DISEASES